Business Valuation Basics for Australian Founders

What "valuation" means when you raise

First distinction to get straight: pre-money and post-money valuation — because one word can move the deal by five points of your company.

Pre-money valuation is what the company is worth before new capital lands. Post-money is what it’s worth after the round adds that capital.¹ Term sheets are built around the pre-money number: it sets the price investors pay per share and how much ownership they receive.²

“Fully diluted” counts every share that exists or could exist: all common stock, issued and unissued options, warrants, and convertible instruments on conversion.²

Now, the one-word trap, and it’s the cheapest question you’ll ever ask: when an investor says “$4M”, is that pre-money or post-money? The difference is your equity.² At a $4M pre-money valuation, a $1M investment buys 20% of the company. At a $4M post-money valuation, the same $1M buys 25%. One word, five points. Ask which number is on the table before anything else gets discussed — it costs you nothing and it’s saved more cap tables than any negotiation tactic.

The dilution maths every founder should be able to do

Every dollar you raise buys newly created shares, and new shares dilute everyone holding the old ones. The division that matters: ownership sold = investment amount ÷ post-money valuation.

Price per share is where founders slip up. In a priced round, the percentage maths only works when the denominator is the correct post-money number. Take a published venture-finance worked case:² a $5M pre-money valuation, 10 million existing shares, and a $1M investment set the price at $0.50 per share. The investor receives 2 million new shares, 12 million shares exist in total, and the investor holds 2 ÷ 12 — about 16.7%, not the 20% a shortcut against the pre-money number would suggest. Quick maths, big difference.

Here’s a founder-friendly rule from YC's Sam Altman on how much equity to give up: sell 10–15% in a seed round, 15–25% in an A round, about 7% through an accelerator, and no more than 30% in total across the early rounds. His law of venture: “there are only 100 points on the cap table.” Companies that reached a B round with investors on 50–60% were, in his account, in all cases having a tough time.³

And here’s the part that surprises most founders: raising less protects your ownership more than negotiating the valuation does. Worth sitting with. Also, model the round rather than eyeballing it — Altman points to Angelcalc, built by then-YC partner Geoff Ralston, and nobody has ever been emotionally attached to a five-year spreadsheet.³

How SAFEs and caps change the picture

A SAFE — Simple Agreement for Future Equity — is a deal that converts into shares at the next priced round, on terms set today. It’s the instrument most pre-seed rounds use, and the maths is refreshingly transparent: on a post-money SAFE, ownership sold = raise amount ÷ valuation cap, and you can work it out the moment you sign. YC's example: target a $1M raise with 15% sold and the cap is $1M ÷ 15% ≈ $6.7M; raise $500K against that cap and you have sold about 7.5%.⁴

The cap is the term that matters later. A discount gives investors a percentage off the next round’s share price — usually the milder term for founders. A valuation cap converts at the capped price even when the round prices far higher: a $10M cap against a $20M round converts as if the company were worth $10M, minting more investor shares and more dilution for you. When a SAFE carries both a cap and a discount, conversion uses whichever produces the lower price per share. And stacking several SAFEs with different caps compounds the effect — startup-finance accountants who model this find small term differences move founder ownership by 5–10+ percentage points by Series A. The catch? Model the terms before you sign them.⁵

Market context, honestly labelled: the most recent US pre-seed dataset⁶ reports the majority of early-stage rounds under $4M close on SAFEs or convertible notes, with median post-money SAFE caps around $10M for $250K–$1M raises and about $15M for $1M–$2.5M raises. That dataset is US-only — no AU cut of this data exists — so treat it as context on how the instrument is used, not an Australian price tag.

What Australian early-stage valuations look like

Here’s the annoying part: nobody publishes a median valuation for Australian early-stage companies. The AU market data reports median round sizes, not company prices. But two accelerator deals put their terms in public, and they’re the closest thing Australia has to a price tag — the honest way to calibrate a first ask:

• Startmate invests A$120K at a A$1.5M post-money valuation cap into each accelerator startup that has not raised before — an implied 8% of the company.⁷
• Antler Australia invests A$225K for 12% — an implied A$1.875M post-money — after lifting its early-stage valuations by 20% (per press coverage).⁸

Those two are the most public day-zero numbers in the country: A$1.5M post-money and A$1.875M post-money. Raising outside a program? Then you price against whatever angels and pre-seed funds in your sector are actually paying — awkward, but that’s the market. For round-size context, Australia's 2025 state-of-funding report⁹ puts median deals at A$1.0M at angel + pre-seed, A$2.5M at seed, and A$11.0M at Series A — round sizes, not valuations. Use them to size the raise, not to price the company.

One Australian tax quirk is worth knowing, because it changes the investor’s economics, not your valuation: where the company qualifies as an early stage innovation company (ESIC), qualifying investors claim a 20% tax offset capped at $200K, plus capital-gains treatment on exit. It changes what an angel effectively pays — which is handy context when an angel’s number seems low.¹⁰

Last thing here, and it’s simple: a valuation pitched to the wrong stage of investor is a targeting failure before it is a pricing failure. Benchmark against the stage you’re actually raising from.

What actually moves a valuation

No single formula produces an early-stage number. Investors layer methods and apply judgment from hundreds of deals, weighted towards three inputs.²

Traction. YC's pitch framework says investors assess “the ratio between what you've done and how long you've been working on it”.¹¹ Product development and customers count first; time served without either doesn’t move the ratio.

Market size. CRV's take: seed investors look for a total addressable market (TAM) in the billion-dollar range or higher, because venture-scale businesses need a credible path to $100M annual revenue. Size it bottom-up — customer counts × unit economics — rather than top-down from market research, and keep capture claims realistic: market-leading horizontal SaaS reaches about 20% of its market over time.¹²

Team. Execution beats pedigree: resilience, learning velocity, coachability, and core technical capability. And a founding team that needs the raise to hire its technical co-founder tends to get rejected quickly.¹²

Australian investors describe the same list. AirTree names team and founder-market fit, the right market, and traction and progress as what it looks for in early-stage investments.¹³ An Australian valuation practice guide¹⁴ adds market potential and size, revenue and growth projections, and strategic position. So while no two investors weigh these identically, you won’t find one arguing the list is wrong.

Methods you'll meet

Four named methods come up in early-stage rooms. Comparable-company analysis anchors on recent revenue multiples for companies at your stage — at seed, comps function “more as an anchoring tool than a precise calculator”.² The venture capital (VC) method works backwards from a projected exit to the price an investor can pay today. For pre-revenue companies, the Berkus Method assigns value across five risk dimensions, and the Scorecard method benchmarks a young company against funded peers.¹⁵¹⁶

Treat these as vocabulary, not homework. None of them outputs “your number” — investors apply judgment across hundreds of deals, and any method is only as good as the inputs you can defend: traction, market, team.

The over-valuation trap

Over-pricing is the founder mistake that can cost you the next round. Not will — can — and the mechanism is documented by practitioners who have facilitated or participated in more than 10,000 fundraises.¹⁷ Two ways it bites:

The reset. You start too high, the market rejects the number, and you reset lower — having burned your best introductions. Raising the lower number is many times harder than starting there would have been.

The time bomb. You close the high round, then don’t accomplish enough to warrant a meaningful step-up (2x or better) at the next raise. The next round starts to look like a bridge or a down round, which spooks investors, and these rounds often fail to come together. Bridge rounds have poor success rates for VCs and get priced accordingly; industry funding-data coverage of overfunding reaches the same conclusion — overvaluation causes problems in subsequent rounds.¹⁷¹⁸

So the practical stance: a fair market-clearing number beats an aspirational one. Price to close the round you need, on terms that set up the next one.¹⁷

The counterweight, before anyone takes this too far: the dilution bands above are guardrails, not a ceiling to die under. YC's own framing — “it's more important not to run out of money than almost anything else.”³

And there’s an Australian reason your number has to be defensible. Moneysmart, ASIC's financial-literacy site, requires retail investors buying startup shares through crowd-sourced funding to declare they understand a formal risk warning, and caps annual retail investment through CSF at $10,000 per company.¹⁹ Australian regulation itself treats early-stage equity as high-risk territory — assume the people reading your valuation have been told exactly that.

Worked example: A$500K SAFE to a priced seed round

The example below is illustrative arithmetic on the published formulas above — no Australian round is being described, and the figures are rounded for readability.

In two sentences: a A$500K SAFE on a A$2.5M cap sells 20% of your company up front, and a later A$1M raise at A$4M pre-money sells a further 20% of what remains — leaving you near 64% before any option pool.

Now the caveat that actually matters: this example ignores the option pool. Increasing the pool pre-money is a real dilution lever.¹ Actual SAFE conversions also follow the instrument’s terms — caps and discounts included — and small term differences move founder ownership by 5–10+ points. Model the round before you sign it.⁵

Where a valuation review fits

And that’s business valuation basics: the terms, the dilution maths, the Australian benchmarks, and the trap. The next step is pointing all of it at your own cap table and the raise you’re planning — the numbers you’re about to ask an investor for, checked before an investor checks them for you.

A valuation review is step one of PitchReady™ Phase 1 Assess: what your current numbers imply, which benchmarks they sit against, and what an investor will question. From there, Strategy positions the company at a price investors can underwrite.

If a raise is coming and the valuation question is still unresolved, book a readiness session. Bring your cap table and the round you’re planning. Leave with the maths checked and the benchmarks your number will be measured against.